Table 1. Total epidemic characteristics of MP infection in adults and children from 2014 to 2020.
Characteristics | Total (n, %) | Children (n, %) | Adult (n, %) | P value* |
---|---|---|---|---|
Year | ||||
2014 | 1,885/7,988 (23.60) | 1,495/5,554 (26.91) | 390/2,434 (16.02) | <0.0001 |
2015 | 2,985/10,593 (28.18) | 2,563/7,011 (36.56) | 422/3,582 (11.78) | <0.0001 |
2016 | 4,188/10,998 (38.08) | 3,574/7,723 (46.28) | 614/3,275 (18.19) | <0.0001 |
2017 | 3,707/13,704 (27.05) | 3,025/8,709 (37.44) | 682/4,995 (13.65) | <0.0001 |
2018 | 3,092/13,191 (23.44) | 2,412/8,641 (27.91) | 680/4,550 (14.95) | <0.0001 |
2019 | 4,392/17,386 (25.26) | 4,189/12,986 (32.25) | 203/4,400 (4.61) | <0.0001 |
2020 | 1,333/7,271 (18.33) | 1,244/5,034 (24.71) | 89/2,237 (3.98) | <0.0001 |
Gender | ||||
Male | 9,246/40,683 (22.72) | 8,113/27,261 (29.76) | 1,133/13,422 (8.44) | <0.0001 |
Female | 12,336/40,448 (30.50) | 10,389/28,397 (36.58) | 1,947/12,051 (16.02) | <0.0001 |
P value# | <0.0001 | <0.0001 | <0.0001 |
*, compared to children and adults; #, compared to males and females. MP, Mycoplasma pneumoniae.